SAFETY AND IMMUNOGENICITY OF AGS-V PLUS, A MOSQUITO SALIVA PEPTIDE VACCINE AGAINST ARBOVIRAL DISEASES

Authors
Category Primary study
ConferenceAmerican Society of Tropical Medicine and Hygiene Annual Meeting, ASTMH 2021
Year 2021
This article has no abstract
Epistemonikos ID: 5ca06fa8710de8c5cb54c145109c60b2a431f6d5
First added on: Mar 15, 2025